Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
600MPE
HR+
Luminal
Nilotinib
ABL
nRTK
12224.145
uM
inf
inf
0.9894 0.9894 0.0000 -0.0249
-0.6099
0.9737
600MPE
HR+
Luminal
PS-1145
IKK
NFKB
5898.065
uM
inf
inf
0.9898 0.9898 0.0000 0.1430
0.0000
0.6845
HCC1395
TNBC
Basal B
Methotrexate
DHFR
Metabolism
7435.084
uM
inf
inf
0.9904 0.9904 0.0000 0.0540
0.2974
0.8646
UACC-812
HER2amp
Luminal
Nelfinavir
13078.174
uM
inf
inf
0.9914 0.9914 0.0000 0.0487
0.0000
0.6238
HBL-100
Unknown
Unknown
AG1024
IGF1R
RTK
7429.066
uM
inf
inf
0.9919 0.9919 0.0000 0.0080
0.0137
2.3904
MDA-MB-453
TNBC
Luminal
GSK1838705A
IGF1R
RTK
7515.092
uM
inf
inf
0.9927 0.9927 0.0000 0.1054
0.0039
1.2024
HCC38
TNBC
Basal B
Lapatinib
EGFR/HER2
ErbB
7469.098
uM
inf
inf
0.9936 0.9936 0.0000 0.0222
0.1591
2.0111
BT-549
TNBC
Basal B
Cetuximab
EGFR
ErbB
10261.026
uM
inf
inf
0.9943 0.9943 0.0000 -0.0202
-1.1867
2.4866
HBL-100
Unknown
Unknown
Cetuximab
EGFR
ErbB
7808.052
uM
inf
inf
0.9944 0.9944 0.0000 -0.0231
-0.8225
2.4842
BT-20
TNBC
Basal A
Methotrexate
DHFR
Metabolism
5902.084
uM
inf
inf
0.9945 0.9945 0.0000 -0.0077
-0.0317
1.3532
Hs 578T
TNBC
Basal B
Dichloroacetate
PDK
PDK
12622.176
uM
inf
inf
0.9947 0.9947 0.0000 -0.0101
-0.9347
2.5005
MDA-MB-157
TNBC
Basal B
Cetuximab
EGFR
ErbB
7879.018
uM
inf
inf
0.9952 0.9952 0.0000 -0.0245
-1.0109
1.7910
MDA-MB-453
TNBC
Luminal
Cetuximab
EGFR
ErbB
7903.042
uM
inf
inf
0.9956 0.9956 0.0000 -0.0024
-0.0113
1.1508
HCC1187
TNBC
Basal A
Ro 32-0432
PKC
PKC
10518.142
uM
inf
inf
0.9965 0.9965 0.0000 0.0075
0.0002
1.2869
MCF7
HR+
Luminal
Cetuximab
EGFR
ErbB
9583.026
uM
inf
inf
0.9966 0.9966 0.0000 0.0156
-0.0344
1.2731
SK-BR-3
HER2amp
Luminal
FTase Inhibitor I
Ftase
MAPK
11851.154
uM
inf
inf
0.9971 0.9971 0.0000 0.0156
0.0000
1.1765
184A1
NM
Basal
FTase Inhibitor I
Ftase
MAPK
12509.167
uM
inf
inf
0.9988 0.9988 0.0000 -0.0033
-0.0009
1.4256
HCC38
TNBC
Basal B
GW843682X
PLK
PLK
10578.139
uM
inf
inf
0.9988 0.9988 0.0000 -0.0137
-0.1933
1.6434
BT-20
TNBC
Basal A
AG1024
IGF1R
RTK
5902.066
uM
inf
inf
0.9990 0.9990 0.0000 -0.0235
-0.9254
1.1775
HCC1937
TNBC
Basal A
GW-5074
CRAF
MAPK
7453.088
uM
inf
inf
0.9998 0.9998 0.0000 -0.0300
-1.8689
1.5634
HCC202
HER2amp
Luminal
GSK1838705A
IGF1R
RTK
7458.091
uM
inf
inf
1.0005 1.0005 0.0000 0.1959
0.0969
0.5499
HCC1395
TNBC
Basal B
Cetuximab
EGFR
ErbB
7816.042
uM
inf
inf
1.0005 1.0005 0.0000 -0.0101
-0.0006
0.9332
Hs 578T
TNBC
Basal B
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7475.095
uM
inf
inf
1.0008 1.0008 0.0000 -0.0341
-3.2051
2.2334
HCC1937
TNBC
Basal A
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7453.084
uM
inf
inf
1.0008 1.0008 0.0000 -0.0055
-0.0025
1.5592
HCC70
TNBC
Basal A
GW-5074
CRAF
MAPK
7470.088
uM
inf
inf
1.0012 1.0012 0.0000 -0.0041
-0.0107
1.1071